Results 21 to 30 of about 547,171 (369)
Fibroblast Growth Factor 23 and Osteoporosis: Evidence from Bench to Bedside
International Journal of Molecular Sciences, 2022 Osteoporosis is a chronic debilitating disease caused by imbalanced bone remodeling processes that impair the structural integrity of bone. Over the last ten years, the association between fibroblast growth factor 23 (FGF23) and osteoporosis has been ...
Wachiranun Sirikul +3 more
semanticscholar +1 more source
The Measurement and Interpretation of Fibroblast Growth Factor 23 (FGF23) Concentrations
Calcified Tissue International, 2022 Two decades after the discovery of the hormone FGF23, we know more about phosphate homeostasis as it turned out that FGF23 is the central hormone that regulates this.
A. Heijboer, E. Cavalier
semanticscholar +1 more source
Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease
Bone Research, 2021 Bone-produced fibroblast growth factor 23 (FGF23) increases in response to inflammation and iron deficiency and contributes to cardiovascular mortality in chronic kidney disease (CKD). Neutrophil gelatinase-associated lipocalin (NGAL or lipocalin 2; LCN2
G. Courbon +10 more
semanticscholar +1 more source
Drugs in Context, 2021 Third-generation intravenous (i.v.) iron preparations are safe and efficacious and are increasingly used in the treatment of iron-deficiency anaemia.
X. Kassianides, S. Bhandari
semanticscholar +1 more source
Extracellular sodium regulates fibroblast growth factor 23 (FGF23) formation. [PDF]
J Biol Chem, 2023 The bone-derived hormone fibroblast growth factor-23 (FGF23) has recently received much attention due to its association with chronic kidney disease and cardiovascular disease progression.
Radvanyi Z +16 more
europepmc +6 more sources
Aging, 2021 Cardiorenal syndrome (CRS) has a high mortality, but its pathogenesis remains elusive. Fibroblast growth factor 23 (FGF23) is increased in both renal dysfunction and cardiac dysfunction, and FGF receptor 4 (FGFR4) has been identified as a receptor for ...
Huixin Hao +14 more
semanticscholar +1 more source
Potassium intake, fibroblast growth factor 23 and clinical outcomes [PDF]
, 2023 Chronic kidney disease (CKD) is a major cause of cardiovascular disease and premature death. Characteristic of some patients with CKD is, among other things, a tendence to develop high levels of phosphate and fibroblast growth factor (FGF23) in the blood,
Yeung, Stanley
core +1 more source
Coupling chemotaxis and growth poromechanics for the modelling of feather primordia patterning [PDF]
Mathematics, year 2022, volume 10, paper 4096, 2022 We propose a new mathematical model for the interaction of skin cell populations with fibroblast growth factor and bone morphogenetic protein, occurring within deformable porous media. The equations for feather primordia pattering are based on the work by K.J. Painter et al. [J. Theoret. Biol., 437 (2018) 225--238].
arxiv +1 more source
Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23)
Journal of molecular medicine, 2021 Fibroblast growth factor 23 (FGF23) is a hormone mainly secreted by bone cells. Its most prominent effects are the regulation of renal phosphate reabsorption and calcitriol (active vitamin D, 1,25(OH)2D3) formation, effects dependent on its co-receptor ...
M. Feger +7 more
semanticscholar +1 more source
Oral Acid Load Down-Regulates Fibroblast Growth Factor 23 [PDF]
, 2022 Increased dietary acid load has a negative impact on health, particularly when renal function is compromised. Fibroblast growth factor 23 (FGF23) is a bone-derived hormone that is elevated during renal failure. The relationship between metabolic acidosis
Aguilera Tejero, Escolástico +8 more
core +1 more source